These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36560842)

  • 1. Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis.
    Pantiora E; Tasoulis MK; Valachis A; Eriksson S; Kühn T; Karakatsanis A; Rubio IT
    Br J Surg; 2023 Mar; 110(4):410-419. PubMed ID: 36560842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-Low Dose of Superparamagnetic Iron Oxide Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer.
    Mirzaei N; Wärnberg F; Zaar P; Leonhardt H; Olofsson Bagge R
    Ann Surg Oncol; 2023 Sep; 30(9):5685-5689. PubMed ID: 37314544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.
    Karakatsanis A; Daskalakis K; Stålberg P; Olofsson H; Andersson Y; Eriksson S; Bergkvist L; Wärnberg F
    Br J Surg; 2017 Nov; 104(12):1675-1685. PubMed ID: 28877348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study).
    Vidya R; Khosla M; Laws S; Harvey J; Kaushik M; Mullapudi NA; Macmillan D
    Surgeon; 2023 Apr; 21(2):128-134. PubMed ID: 35551871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial.
    Man V; Suen D; Kwong A
    Ann Surg Oncol; 2023 Jun; 30(6):3237-3244. PubMed ID: 36849573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity - The MAGMEN feasibility study.
    Mirzaei N; Katsarelias D; Zaar P; Jalnefjord O; Johansson I; Leonhardt H; Wärnberg F; Olofsson Bagge R
    Eur J Surg Oncol; 2022 Feb; 48(2):326-332. PubMed ID: 35000820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel Lymph Node Biopsy in Early Breast Cancer: Magnetic Tracer as the Only Localizing Agent.
    Man V; Wong TT; Co M; Suen D; Kwong A
    World J Surg; 2019 Aug; 43(8):1991-1996. PubMed ID: 30888473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
    Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
    Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-assisted carbon nanoparticle suspension mapping versus dual tracer-guided sentinel lymph node biopsy in patients with early breast cancer (ultraCars): phase III randomized clinical trial.
    Zhang L; Cheng M; Lin Y; Zhang J; Shen B; Chen Y; Yang C; Yang M; Zhu T; Gao H; Ji F; Li J; Wang K
    Br J Surg; 2022 Nov; 109(12):1232-1238. PubMed ID: 36074703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.
    Alvarado MD; Mittendorf EA; Teshome M; Thompson AM; Bold RJ; Gittleman MA; Beitsch PD; Blair SL; Kivilaid K; Harmer QJ; Hunt KK
    Ann Surg Oncol; 2019 Oct; 26(11):3510-3516. PubMed ID: 31297674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetically guided surgery after primary systemic therapy for breast cancer: implications for enhanced axillary mapping.
    Pantiora E; Eriksson S; Wärnberg F; Karakatsanis A
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38325801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
    Thongvitokomarn S; Polchai N
    Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
    Karakatsanis A; Christiansen PM; Fischer L; Hedin C; Pistioli L; Sund M; Rasmussen NR; Jørnsgård H; Tegnelius D; Eriksson S; Daskalakis K; Wärnberg F; Markopoulos CJ; Bergkvist L
    Breast Cancer Res Treat; 2016 Jun; 157(2):281-294. PubMed ID: 27117158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New techniques versus standard mapping for sentinel lymph node biopsy in breast cancer: a systematic review and meta-analysis.
    Rocco N; Velotti N; Pontillo M; Vitiello A; Berardi G; Accurso A; Masone S; Musella M
    Updates Surg; 2023 Sep; 75(6):1699-1710. PubMed ID: 37326934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
    Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
    Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
    Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
    Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
    Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node mapping with superparamagnetic iron oxide for melanoma: a pilot study in healthy participants to establish an optimal MRI workflow protocol.
    Aldenhoven L; Frotscher C; Körver-Steeman R; Martens MH; Kuburic D; Janssen A; Beets GL; van Bastelaar J
    BMC Cancer; 2022 Oct; 22(1):1062. PubMed ID: 36241982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer.
    Ahmed M; Purushotham AD; Horgan K; Klaase JM; Douek M
    Br J Surg; 2015 Feb; 102(3):169-81. PubMed ID: 25511661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.